This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Patrick Knerr, Ph.D.
Research Scientist II - Chemistry at Novo Nordisk Research Center Indianapoli


Patrick J. Knerr obtained his BS in Biochemistry from the University of Delaware and his PhD in Chemistry from the University of Illinois Urbana-Champaign. He joined the Novo Nordisk Research Center in Indianapolis, IN, in 2016 as a peptide medicinal chemist. His research focuses on peptide-based drug discovery for metabolic and rare endocrine diseases, with particular interest in proglucagon-derived metabolic hormones.

Agenda Sessions

  • Discovery and Optimization of Long-acting, Unimolecular Peptide Triple Agonists of the GLP-1, GIP, and Glucagon Receptors